Reportedly, the scientists said their study dubbed D(MG)2 could make the way to understanding more about the disease that led to the death of Karen Armstrong, daughter of the late US astronaut Neil Armstrong.
Some researchers at the Institute of Cancer Research are sending diffuse midline glioma samples to the International Space Station to check how it spreads in microgravity.
Diffuse midline glioma is an aggressive and incurable brain tumor that occurs most commonly in children.
The researchers want the experiments to be done in microgravity because they believe the conditions will allow their 3D cultures to grow to much larger sizes than on Earth.
This will permit for larger, full-scale models in which to study how cancer cells interact as that is believed to drive growth.
Reportedly, the launch is expected to take place in 2025 and the experiments will be carried out by astronauts on board with samples expected to be returned to Earth around six months later.
